Akèy › Psoryaz › Pennsylvania › Philadelphia
Etid klinik pou Psoryaz nan Philadelphia, PA
5 etid pou Psoryaz ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
Ap rekriteFaz 2
- LEO Pharma Investigational Site, Philadelphia
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Ap rekriteFaz 4
- Dermatology Associates of Plymouth Meeting, Plymouth Meeting · 12 mi lwen
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Ap rekriteFaz 3
- Paddington Testing Company, Philadelphia
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
Ap rekriteFaz 2
- Study Center, Philadelphia
Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques
Ap rekriteFaz 1
- Temple University, Philadelphia
Etid Psoryaz nan lòt vil
- Trenton, NJ7 etid
- Newton, MA6 etid
- Cleveland, OH6 etid
- New York City, NY5 etid
- San Antonio, TX5 etid
- Fremont, CA5 etid
- Huntington Beach, CA4 etid
- Birmingham, AL4 etid
- San Diego, CA3 etid
- Rochester, NY3 etid
- Columbus, OH3 etid
- Sacramento, CA3 etid
Lòt etid nan Philadelphia
- Kansè (tout kalite)59 etid
- Kansè nan tete56 etid
- Kansè Poumon ki pa ti selil51 etid
- Kansè Metastatik46 etid
- Kansè kolorektal44 etid
- Kansè ovè44 etid
- Kansè pwostat44 etid
- Kansè poumon36 etid
- Leksemi mieloïd egi34 etid
- Ensifizyans kadyak31 etid
- Kansè Endomèt28 etid
- Depresyon26 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.